Michele Marie Burns, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Poisons | 3 | 2023 | 38 | 1.890 |
Why?
|
Poisoning | 7 | 2020 | 252 | 1.570 |
Why?
|
Caustics | 4 | 2024 | 32 | 1.450 |
Why?
|
Burns, Chemical | 4 | 2024 | 123 | 1.400 |
Why?
|
Clonidine | 2 | 2020 | 169 | 1.340 |
Why?
|
Legislation, Drug | 2 | 2020 | 214 | 1.180 |
Why?
|
Cannabis | 3 | 2023 | 441 | 1.060 |
Why?
|
Antidotes | 5 | 2023 | 138 | 0.960 |
Why?
|
Poison Control Centers | 3 | 2023 | 76 | 0.960 |
Why?
|
Abortifacient Agents | 1 | 2023 | 11 | 0.870 |
Why?
|
Hypoglycemia | 2 | 2023 | 883 | 0.860 |
Why?
|
Detergents | 2 | 2020 | 236 | 0.850 |
Why?
|
Drug Compounding | 2 | 2020 | 245 | 0.820 |
Why?
|
Bradycardia | 2 | 2023 | 299 | 0.810 |
Why?
|
Thiocyanates | 1 | 2022 | 70 | 0.800 |
Why?
|
Misoprostol | 1 | 2023 | 93 | 0.790 |
Why?
|
Antitussive Agents | 1 | 2021 | 18 | 0.780 |
Why?
|
Hallucinogens | 2 | 2023 | 197 | 0.770 |
Why?
|
Performance-Enhancing Substances | 1 | 2022 | 30 | 0.770 |
Why?
|
Doping in Sports | 1 | 2022 | 62 | 0.760 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.760 |
Why?
|
Cannabinoids | 1 | 2024 | 172 | 0.760 |
Why?
|
Bupropion | 1 | 2023 | 304 | 0.750 |
Why?
|
Pharmacies | 1 | 2023 | 167 | 0.740 |
Why?
|
Naloxone | 2 | 2020 | 370 | 0.710 |
Why?
|
Acidosis | 1 | 2022 | 268 | 0.690 |
Why?
|
Toxicology | 1 | 2020 | 102 | 0.660 |
Why?
|
Drug Contamination | 1 | 2020 | 151 | 0.660 |
Why?
|
Blood Coagulation Disorders | 1 | 2022 | 350 | 0.650 |
Why?
|
Long QT Syndrome | 1 | 2023 | 466 | 0.630 |
Why?
|
Chloroquine | 1 | 2020 | 275 | 0.630 |
Why?
|
Methadone | 2 | 2018 | 321 | 0.610 |
Why?
|
Cough | 1 | 2021 | 595 | 0.580 |
Why?
|
Hypotension | 1 | 2023 | 879 | 0.570 |
Why?
|
Abortion, Induced | 1 | 2023 | 461 | 0.560 |
Why?
|
Dextroamphetamine | 1 | 2016 | 134 | 0.530 |
Why?
|
Pharmaceutical Preparations | 2 | 2023 | 1086 | 0.520 |
Why?
|
Artificial Intelligence | 2 | 2021 | 2575 | 0.520 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.520 |
Why?
|
Sodium Bicarbonate | 1 | 2016 | 60 | 0.520 |
Why?
|
Sports | 1 | 2022 | 705 | 0.500 |
Why?
|
Psychotropic Drugs | 2 | 2023 | 888 | 0.500 |
Why?
|
Data Mining | 1 | 2020 | 551 | 0.480 |
Why?
|
Marijuana Smoking | 1 | 2018 | 258 | 0.480 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2016 | 123 | 0.480 |
Why?
|
Esophageal Stenosis | 3 | 2020 | 197 | 0.460 |
Why?
|
Vaccines | 1 | 2023 | 838 | 0.460 |
Why?
|
Drug Industry | 1 | 2020 | 788 | 0.450 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2023 | 1081 | 0.450 |
Why?
|
Arrhythmias, Cardiac | 3 | 2024 | 2234 | 0.400 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2016 | 763 | 0.390 |
Why?
|
Antiviral Agents | 2 | 2022 | 3037 | 0.380 |
Why?
|
Evidence-Based Medicine | 2 | 2023 | 3680 | 0.370 |
Why?
|
Heart Conduction System | 1 | 2016 | 992 | 0.360 |
Why?
|
Child | 26 | 2023 | 80089 | 0.350 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2024 | 432 | 0.350 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2016 | 1048 | 0.340 |
Why?
|
Heart Diseases | 1 | 2021 | 2778 | 0.310 |
Why?
|
Humans | 58 | 2024 | 760740 | 0.310 |
Why?
|
Central Nervous System Stimulants | 1 | 2016 | 1177 | 0.300 |
Why?
|
Epilepsy | 1 | 2023 | 3303 | 0.300 |
Why?
|
Immunotherapy | 1 | 2023 | 4642 | 0.280 |
Why?
|
Research Design | 1 | 2022 | 6174 | 0.270 |
Why?
|
Communication | 1 | 2020 | 3851 | 0.260 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9171 | 0.260 |
Why?
|
Narcotic Antagonists | 3 | 2018 | 585 | 0.240 |
Why?
|
Eye Burns | 1 | 2005 | 65 | 0.230 |
Why?
|
Heart Rate | 1 | 2016 | 4181 | 0.230 |
Why?
|
Doxepin | 1 | 2023 | 16 | 0.230 |
Why?
|
Eating | 2 | 2023 | 1535 | 0.230 |
Why?
|
Plant Poisoning | 1 | 2023 | 13 | 0.230 |
Why?
|
Foodborne Diseases | 1 | 2023 | 41 | 0.220 |
Why?
|
Ophthalmic Solutions | 1 | 2005 | 312 | 0.220 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2023 | 107 | 0.210 |
Why?
|
Hydrogen Sulfide | 1 | 2004 | 141 | 0.210 |
Why?
|
Ivermectin | 1 | 2022 | 46 | 0.210 |
Why?
|
Xenobiotics | 1 | 2022 | 70 | 0.210 |
Why?
|
Charcoal | 2 | 2016 | 67 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.200 |
Why?
|
Adolescent | 16 | 2023 | 88247 | 0.200 |
Why?
|
Esophagoscopy | 1 | 2024 | 398 | 0.200 |
Why?
|
Mifepristone | 1 | 2023 | 151 | 0.200 |
Why?
|
Cyanides | 1 | 2022 | 82 | 0.190 |
Why?
|
Ataxia | 1 | 2023 | 306 | 0.190 |
Why?
|
Borates | 1 | 2020 | 19 | 0.180 |
Why?
|
Child, Preschool | 12 | 2023 | 42193 | 0.180 |
Why?
|
Tachycardia | 1 | 2023 | 597 | 0.180 |
Why?
|
Asymptomatic Diseases | 1 | 2024 | 587 | 0.180 |
Why?
|
Sodium Hypochlorite | 1 | 2020 | 31 | 0.180 |
Why?
|
Analgesics, Opioid | 4 | 2022 | 3805 | 0.180 |
Why?
|
Phenol | 1 | 2020 | 44 | 0.180 |
Why?
|
International Normalized Ratio | 1 | 2022 | 381 | 0.180 |
Why?
|
Environmental Health | 1 | 2023 | 288 | 0.180 |
Why?
|
Seizures | 2 | 2023 | 2964 | 0.180 |
Why?
|
Carbamazepine | 2 | 2017 | 224 | 0.170 |
Why?
|
Anti-Obesity Agents | 1 | 2023 | 227 | 0.170 |
Why?
|
Esophageal Perforation | 1 | 2020 | 64 | 0.170 |
Why?
|
Vitamin K | 1 | 2022 | 313 | 0.170 |
Why?
|
Rhode Island | 1 | 2020 | 351 | 0.170 |
Why?
|
Household Products | 1 | 2019 | 27 | 0.170 |
Why?
|
Calcium Channel Blockers | 1 | 2023 | 694 | 0.170 |
Why?
|
Buprenorphine | 2 | 2018 | 656 | 0.170 |
Why?
|
Fentanyl | 2 | 2022 | 433 | 0.170 |
Why?
|
Knowledge Bases | 1 | 2020 | 97 | 0.170 |
Why?
|
Ammonia | 1 | 2020 | 237 | 0.170 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2020 | 91 | 0.160 |
Why?
|
Poisson Distribution | 1 | 2020 | 504 | 0.160 |
Why?
|
Vocabulary, Controlled | 1 | 2020 | 167 | 0.160 |
Why?
|
Rectum | 1 | 2023 | 891 | 0.160 |
Why?
|
Hypnotics and Sedatives | 2 | 2017 | 1178 | 0.150 |
Why?
|
Carbon Monoxide Poisoning | 1 | 2018 | 65 | 0.150 |
Why?
|
Vomiting | 2 | 2019 | 651 | 0.150 |
Why?
|
Pandemics | 3 | 2023 | 8652 | 0.150 |
Why?
|
Critical Care | 2 | 2023 | 2691 | 0.150 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2023 | 1241 | 0.150 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11458 | 0.140 |
Why?
|
Infant | 9 | 2023 | 36157 | 0.140 |
Why?
|
Weather | 1 | 2018 | 231 | 0.140 |
Why?
|
Massachusetts | 2 | 2020 | 8835 | 0.140 |
Why?
|
Analgesics | 2 | 2021 | 1067 | 0.140 |
Why?
|
Barbiturates | 1 | 2017 | 113 | 0.140 |
Why?
|
Female | 21 | 2024 | 392203 | 0.140 |
Why?
|
Male | 18 | 2024 | 360402 | 0.140 |
Why?
|
Markov Chains | 1 | 2020 | 965 | 0.130 |
Why?
|
Narcotics | 1 | 2018 | 335 | 0.130 |
Why?
|
Authorship | 1 | 2019 | 284 | 0.130 |
Why?
|
History, 20th Century | 2 | 2020 | 2764 | 0.130 |
Why?
|
Diphenhydramine | 1 | 2015 | 63 | 0.130 |
Why?
|
United States | 8 | 2023 | 72292 | 0.120 |
Why?
|
Sodium Channel Blockers | 1 | 2016 | 172 | 0.120 |
Why?
|
Drug Costs | 1 | 2023 | 1183 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1566 | 0.120 |
Why?
|
Opiate Substitution Treatment | 1 | 2018 | 444 | 0.120 |
Why?
|
Athletes | 1 | 2022 | 1137 | 0.110 |
Why?
|
Medication Errors | 1 | 2020 | 783 | 0.110 |
Why?
|
Warfarin | 1 | 2022 | 1477 | 0.110 |
Why?
|
Occupational Exposure | 1 | 2004 | 1813 | 0.110 |
Why?
|
Coma | 1 | 2017 | 484 | 0.110 |
Why?
|
Antimony Potassium Tartrate | 1 | 2012 | 3 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2023 | 80583 | 0.100 |
Why?
|
Adult | 10 | 2024 | 220995 | 0.100 |
Why?
|
Disasters | 1 | 2018 | 520 | 0.100 |
Why?
|
Young Adult | 5 | 2023 | 59191 | 0.100 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 625 | 0.100 |
Why?
|
Publishing | 1 | 2019 | 832 | 0.100 |
Why?
|
Health Status Indicators | 1 | 2017 | 970 | 0.100 |
Why?
|
Drug Interactions | 1 | 2016 | 1415 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1669 | 0.090 |
Why?
|
Consciousness Disorders | 1 | 2015 | 441 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2020 | 2160 | 0.090 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 521 | 0.090 |
Why?
|
Hemorrhage | 1 | 2022 | 3418 | 0.090 |
Why?
|
Prescription Drugs | 1 | 2017 | 631 | 0.090 |
Why?
|
Anticonvulsants | 2 | 2016 | 1910 | 0.090 |
Why?
|
Antimalarials | 1 | 2016 | 907 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1748 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12966 | 0.080 |
Why?
|
Electrocardiography | 2 | 2024 | 6346 | 0.080 |
Why?
|
Action Potentials | 1 | 2016 | 1825 | 0.080 |
Why?
|
Databases, Factual | 1 | 2023 | 7963 | 0.070 |
Why?
|
Suicide, Attempted | 1 | 2016 | 1402 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.070 |
Why?
|
Software | 1 | 2021 | 4432 | 0.070 |
Why?
|
Anticoagulants | 1 | 2022 | 4785 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2977 | 0.070 |
Why?
|
Delirium | 1 | 2017 | 1667 | 0.060 |
Why?
|
Pediatrics | 2 | 2017 | 3589 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8516 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2019 | 26183 | 0.060 |
Why?
|
Confined Spaces | 1 | 2004 | 10 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 21339 | 0.060 |
Why?
|
Histoplasmosis | 1 | 2004 | 63 | 0.060 |
Why?
|
Androstanes | 1 | 2023 | 20 | 0.060 |
Why?
|
2,4-Dinitrophenol | 1 | 2023 | 13 | 0.060 |
Why?
|
Dinitrophenols | 1 | 2023 | 56 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 2164 | 0.060 |
Why?
|
High-Frequency Ventilation | 1 | 2004 | 88 | 0.060 |
Why?
|
Therapeutic Irrigation | 1 | 2005 | 289 | 0.050 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2023 | 1017 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20077 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 41464 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2023 | 260 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5878 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29869 | 0.050 |
Why?
|
Sucralfate | 1 | 2020 | 12 | 0.050 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2004 | 662 | 0.040 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2004 | 410 | 0.040 |
Why?
|
Alkalies | 1 | 2020 | 44 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 2495 | 0.040 |
Why?
|
Toxicity Tests | 1 | 2000 | 115 | 0.040 |
Why?
|
Acids | 1 | 2020 | 125 | 0.040 |
Why?
|
Product Labeling | 1 | 2020 | 76 | 0.040 |
Why?
|
Mitomycin | 1 | 2020 | 263 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2004 | 1835 | 0.040 |
Why?
|
Hospitalization | 2 | 2016 | 10708 | 0.040 |
Why?
|
Acetaminophen | 1 | 2023 | 555 | 0.040 |
Why?
|
Naltrexone | 1 | 2001 | 317 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2023 | 5292 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2001 | 394 | 0.040 |
Why?
|
Risk Factors | 4 | 2023 | 74128 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26065 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2120 | 0.040 |
Why?
|
Registries | 2 | 2024 | 8209 | 0.040 |
Why?
|
Hemodiafiltration | 1 | 2017 | 18 | 0.040 |
Why?
|
Occupational Health | 1 | 2004 | 806 | 0.040 |
Why?
|
Endoscopy, Digestive System | 1 | 2020 | 353 | 0.040 |
Why?
|
Decontamination | 1 | 2017 | 73 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2017 | 206 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1550 | 0.030 |
Why?
|
Peer Review, Research | 1 | 2019 | 339 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29601 | 0.030 |
Why?
|
Government Regulation | 1 | 2020 | 524 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2017 | 1795 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23974 | 0.030 |
Why?
|
Esophagus | 1 | 2020 | 1031 | 0.030 |
Why?
|
Oximetry | 1 | 2016 | 459 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1116 | 0.030 |
Why?
|
Emergency Service, Hospital | 2 | 2023 | 7873 | 0.030 |
Why?
|
Length of Stay | 2 | 2016 | 6418 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2023 | 2768 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3727 | 0.020 |
Why?
|
Odds Ratio | 1 | 2023 | 9644 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1878 | 0.020 |
Why?
|
Steroids | 1 | 2016 | 928 | 0.020 |
Why?
|
Liver Failure, Acute | 1 | 2012 | 181 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 64572 | 0.020 |
Why?
|
Lung Diseases | 1 | 2019 | 1909 | 0.020 |
Why?
|
Operating Rooms | 1 | 2016 | 790 | 0.020 |
Why?
|
Suicide | 1 | 2019 | 1601 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1463 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54364 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 1230 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1859 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4790 | 0.020 |
Why?
|
Trinidad and Tobago | 1 | 2004 | 13 | 0.020 |
Why?
|
Chills | 1 | 2004 | 17 | 0.020 |
Why?
|
Oxygen | 1 | 2016 | 4226 | 0.020 |
Why?
|
Antigens, Fungal | 1 | 2004 | 69 | 0.010 |
Why?
|
Critical Illness | 1 | 2017 | 2709 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2016 | 3743 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14649 | 0.010 |
Why?
|
Midazolam | 1 | 2001 | 266 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2004 | 858 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 220603 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2000 | 957 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7403 | 0.010 |
Why?
|
Fever | 1 | 2004 | 1618 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2004 | 2197 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 39908 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58919 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2001 | 1921 | 0.010 |
Why?
|
Aged | 1 | 2019 | 169092 | 0.000 |
Why?
|